PMID- 31150387 OWN - NLM STAT- MEDLINE DCOM- 20191115 LR - 20201214 IS - 1553-7358 (Electronic) IS - 1553-734X (Print) IS - 1553-734X (Linking) VI - 15 IP - 5 DP - 2019 May TI - Conformational coupling by trans-phosphorylation in calcium calmodulin dependent kinase II. PG - e1006796 LID - 10.1371/journal.pcbi.1006796 [doi] LID - e1006796 AB - The calcium calmodulin-dependent protein kinase II (CaMKII) is a dodecameric holoenzyme important for encoding memory. Its activation, triggered by binding of calcium-calmodulin, persists autonomously after calmodulin dissociation. One (receiver) kinase captures and subsequently phosphorylates the regulatory domain peptide of a donor kinase forming a chained dimer as the first stage of autonomous activation. Protein dynamics simulations examined the conformational changes triggered by dimer formation and phosphorylation, aimed to provide a molecular rationale for human mutations that result in learning disabilities. Ensembles generated from X-ray crystal structures were characterized by network centrality and community analysis. Mutual information related collective motions to local fragment dynamics encoded with a structural alphabet. Implicit solvent tCONCOORD conformational ensembles revealed the dynamic architecture of inactive kinase domains was co-opted in the activated dimer but the network hub shifted from the nucleotide binding cleft to the captured peptide. Explicit solvent molecular dynamics (MD) showed nucleotide and substrate binding determinants formed coupled nodes in long-range signal relays between regulatory peptides in the dimer. Strain in the extended captured peptide was balanced by reduced flexibility of the receiver kinase C-lobe core. The relays were organized around a hydrophobic patch between the captured peptide and a key binding helix. The human mutations aligned along the relays. Thus, these mutations could disrupt the allosteric network alternatively, or in addition, to altered binding affinities. Non-binding protein sectors distant from the binding sites mediated the allosteric signalling; providing possible targets for inhibitor design. Phosphorylation of the peptide modulated the dielectric of its binding pocket to strengthen the patch, non-binding sectors, domain interface and temporal correlations between parallel relays. These results provide the molecular details underlying the reported positive kinase cooperativity to enrich the discussion on how autonomous activation by phosphorylation leads to long-term behavioural effects. FAU - Pandini, Alessandro AU - Pandini A AUID- ORCID: 0000-0002-4158-233X AD - Department of Computer Science-Synthetic Biology Theme, Brunel University London, Uxbridge, United Kingdom. AD - The Thomas Young Centre for Theory and Simulation of Materials, London, United Kingdom. AD - Computational Cell and Molecular Biology, the Francis Crick Institute, London, United Kingdom. FAU - Schulman, Howard AU - Schulman H AUID- ORCID: 0000-0002-0353-2315 AD - Allosteros Therapeutics Inc., Sunnyvale, CA, United States of America. FAU - Khan, Shahid AU - Khan S AUID- ORCID: 0000-0002-0361-6068 AD - Computational Cell and Molecular Biology, the Francis Crick Institute, London, United Kingdom. AD - Molecular Biology Consortium, Lawrence Berkeley National Laboratory, Berkeley, CA, United States of America. LA - eng GR - R01 GM101277/GM/NIGMS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20190531 PL - United States TA - PLoS Comput Biol JT - PLoS computational biology JID - 101238922 RN - 0 (Calmodulin) RN - EC 2.7.11.17 (Calcium-Calmodulin-Dependent Protein Kinase Type 2) RN - SY7Q814VUP (Calcium) SB - IM MH - Animals MH - Binding Sites MH - Calcium/metabolism MH - Calcium-Calmodulin-Dependent Protein Kinase Type 2/*metabolism/*ultrastructure MH - Calmodulin/metabolism MH - Humans MH - Molecular Dynamics Simulation MH - Phosphorylation/physiology MH - Protein Binding MH - Protein Conformation MH - Signal Transduction PMC - PMC6576796 COIS- HS is a paid employee of Allosteros Therapeutics. EDAT- 2019/06/01 06:00 MHDA- 2019/11/16 06:00 PMCR- 2019/05/31 CRDT- 2019/06/01 06:00 PHST- 2019/01/16 00:00 [received] PHST- 2019/03/28 00:00 [accepted] PHST- 2019/06/17 00:00 [revised] PHST- 2019/06/01 06:00 [pubmed] PHST- 2019/11/16 06:00 [medline] PHST- 2019/06/01 06:00 [entrez] PHST- 2019/05/31 00:00 [pmc-release] AID - PCOMPBIOL-D-19-00018 [pii] AID - 10.1371/journal.pcbi.1006796 [doi] PST - epublish SO - PLoS Comput Biol. 2019 May 31;15(5):e1006796. doi: 10.1371/journal.pcbi.1006796. eCollection 2019 May.